EC Number | Cloned (Comment) | Organism |
---|---|---|
2.4.2.9 | expression of the fusion gene CDUPRT, combining cytosine deaminase combined with uracil phosphoribosyl transferase, in RM1 cancer cells in a gene therapeutic approach, overview | Mus musculus |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.4.2.9 | additional information | expression of fusion protein cytosine deaminase combined with uracil phosphoribosyl transferase leads to local and distant bystander effects against intraprostatic mouse androgen-refractory prostate, RM1, tumors in immunocompetent mice, CDUPRT-GDEPT expression significantly suppresses the aggressive growth of RM1 prostate tumors and lung pseudo-metastases via immune mechanisms involving necrosis and apoptosis, overview | Mus musculus |
3.5.4.1 | additional information | construction of a fusion gene using cytosine deaminase in combination with uracil phosphoribosyl transferase, the product of the suicide gene, CDUPRT, converts the prodrug, 5-fluorocytosine, into 5-fluorouracil and other cytotoxic metabolites that kill both CDUPRT-expressing and surrounding cells, via a bystander effect, in pseudo-metastates in mouse tissues, tissue-specifix effects, overview | Escherichia coli |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.2.9 | 5-fluorouracil + 5-phospho-alpha-D-ribose 1-diphosphate | Mus musculus | recombinant fusion enzyme in RM1 tumors of lung, spleen, heart, and prostate | 5-fluoro-UMP + diphosphate | - |
? | |
3.5.4.1 | 5-fluorocytosine + H2O | Escherichia coli | recombinant enzyme, combination of cytosine deaminase with uracil phosphoribosyl transferase leads to local and distant bystander effects against RM1 prostate cancer in mice in gene-directed enzyme prodrug therapy, overview | 5-fluorouracil + NH3 | - |
? | |
3.5.4.1 | cytosine + H2O | Escherichia coli | - |
uracil + NH3 | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.4.2.9 | Mus musculus | - |
- |
- |
3.5.4.1 | Escherichia coli | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.2.9 | 5-fluorouracil + 5-phospho-alpha-D-ribose 1-diphosphate | recombinant fusion enzyme in RM1 tumors of lung, spleen, heart, and prostate | Mus musculus | 5-fluoro-UMP + diphosphate | - |
? | |
2.4.2.9 | 5-fluorouracil + 5-phospho-alpha-D-ribose 1-diphosphate | recombinant fusion enzyme | Mus musculus | 5-fluoro-UMP + diphosphate | - |
? | |
3.5.4.1 | 5-fluorocytosine + H2O | recombinant enzyme, combination of cytosine deaminase with uracil phosphoribosyl transferase leads to local and distant bystander effects against RM1 prostate cancer in mice in gene-directed enzyme prodrug therapy, overview | Escherichia coli | 5-fluorouracil + NH3 | - |
? | |
3.5.4.1 | 5-fluorocytosine + H2O | activation of the prodrug | Escherichia coli | 5-fluorouracil + NH3 | - |
? | |
3.5.4.1 | cytosine + H2O | - |
Escherichia coli | uracil + NH3 | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.4.2.9 | uracil phosphoribosyl transferase | - |
Mus musculus |